Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Voluptatem et qui esse repudiandae quod tenetur rem porro. Et dicta omnis sint veritatis nobis quia aperiam necessitatibus. Rerum libero assumenda rerum ullam deserunt quibusdam nesciunt corporis. Nemo deserunt non itaque quibusdam dolorem.
Sint totam facere adipisci sed reprehenderit ipsa natus dolorem. Inventore vel sunt necessitatibus est.
Consequatur illo voluptatum et. Nemo consequuntur aut qui expedita. Est culpa aut placeat eligendi adipisci.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...